AMBUB (AMBUB) News
Follow AMBUB (AMBUB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Ambu Obtains Regulatory Clearances For Expanded GI Indication
Ambu A/S OMXCOP:AMBU_B
NEWS | Sep 25, 2026, 06:52 AM UTC
L
Ambu Target Cut to DKK72.00 From DKK96.00 by UBS
Ambu Target Cut to DKK72.00 From DKK96.00 by UBS
NEWS | Sep 15, 2026, 09:43 AM UTC
L
Ambu Cut to Neutral From Buy by UBS
Ambu Cut to Neutral From Buy by UBS
NEWS | Sep 15, 2026, 09:43 AM UTC
M
Ambu to acquire TIMS Medical to advance endointelligence
EQUITY | Sep 14, 2026, 01:15 PM UTC
L
AMBU_B: Endoscopy Solutions drove 16% growth and 13.5% EBIT margin, with strong cash flow and positive outlook
AMBU_B: Endoscopy Solutions drove 16% growth and 13.5% EBIT margin, with strong cash flow and positive outlook
EARNINGS | Aug 26, 2026, 11:39 AM UTC
L
AMBUB Q3 shows 10.3% organic growth, 13.5% EBIT margin
AMBU_B reported Q3 organic growth of 10.3% and an EBIT margin of 13.5%, driven by Endoscopy Solutions.
EARNINGS | Aug 26, 2026, 07:22 AM UTC
L
Ambu reports Q3 EBIT of DKK 221 mln
Ambu reported Q3 EBIT of DKK 221 mln, according to TradingView News.
EARNINGS | Aug 26, 2026, 06:39 AM UTC